663 related articles for article (PubMed ID: 15655264)
1. Pathological proteins in Parkinson's disease: focus on the proteasome.
Snyder H; Wolozin B
J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
[TBL] [Abstract][Full Text] [Related]
5. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
9. Co-association of parkin and alpha-synuclein.
Choi P; Golts N; Snyder H; Chong M; Petrucelli L; Hardy J; Sparkman D; Cochran E; Lee JM; Wolozin B
Neuroreport; 2001 Sep; 12(13):2839-43. PubMed ID: 11588587
[TBL] [Abstract][Full Text] [Related]
10. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
11. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
Lee YC; Hsu SD
Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
[TBL] [Abstract][Full Text] [Related]
12. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
Lansbury PT; Brice A
Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
15. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
16. Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.
Bandopadhyay R; Kingsbury AE; Muqit MM; Harvey K; Reid AR; Kilford L; Engelender S; Schlossmacher MG; Wood NW; Latchman DS; Harvey RJ; Lees AJ
Neurobiol Dis; 2005 Nov; 20(2):401-11. PubMed ID: 15894486
[TBL] [Abstract][Full Text] [Related]
17. New insights into Parkinson's disease.
Chung KK; Dawson VL; Dawson TM
J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
[TBL] [Abstract][Full Text] [Related]
18. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
Lim KL; Dawson VL; Dawson TM
Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
[TBL] [Abstract][Full Text] [Related]
19. New aspects of genetic contributions to Parkinson's disease.
Hofer A; Gasser T
J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
[TBL] [Abstract][Full Text] [Related]
20. Genes, proteins, and neurotoxins involved in Parkinson's disease.
von Bohlen und Halbach O; Schober A; Krieglstein K
Prog Neurobiol; 2004 Jun; 73(3):151-77. PubMed ID: 15236834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]